I am an enthusiastic and experienced reproductive toxicologist supporting the AstraZeneca portfolio and accountable for reproductive testing strategy. My role encompasses study design, contribution to regulatory submissions, product labeling and regulatory defense. I interpret data from literature, toxicology studies and assess clinical plans to advise on contraception requirements, the path to inclusion of women of child bearing potential (WoCBP) and paediatric patient populations in clinical trials. I aim to contribute to the development of drugs which support all patients throughout their reproductive lives including during pregnancy, ensuring that reproductive toxicology can provide not only functional studies to ensure regulatory acceptability, but also consider how to best inform patient of the risk and options. I enjoy making reproductive toxicology accessible and using my knowledge and skills to support the development of others.